FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Genzyme | buyouts | Boston | Ireland

Genzyme gets public backing for $200M expansion

Tools

Genzyme is getting some public backing for a $200 million expansion project in the south of Ireland. The Cambridge, MA-based biotech plans to hire about 170 people as it expands its manufacturing and research operations. Ireland has become a key global player in biopharma over the years, hosting a range of manufacturing and lab facilities. Teva announced its own expansion plans for Waterford last month.

- read the story from the International Herald Tribune

Related Articles:
Genzyme--Big Biotech's Stock Report. Report
Genzyme on buyouts: Thanks but no thanks. Report
Boston officials herald big Genzyme expansion. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Ireland   Genzyme   buyouts   Boston